Agile Therapeutics Inc (AGRX)
0.4178
+0.02
(+4.46%)
USD |
OTCM |
Apr 26, 12:23
Agile Therapeutics Revenue (TTM): 19.59M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.59M |
| September 30, 2023 | 19.97M |
| June 30, 2023 | 16.31M |
| March 31, 2023 | 12.94M |
| December 31, 2022 | 10.88M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.403M |
| June 30, 2022 | 6.688M |
| March 31, 2022 | 5.747M |
| December 31, 2021 | 4.102M |
| September 30, 2021 | 3.337M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.337M
Minimum
Sep 2021
19.97M
Maximum
Sep 2023
10.80M
Average
9.644M
Median
Revenue (TTM) Benchmarks
| Altimmune Inc | 0.426M |
| iBio Inc | -- |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |